You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial
|
|---|---|
| Published in |
Annals of the Rheumatic Diseases, August 2012
|
| DOI | 10.1136/annrheumdis-2012-201611 |
| Pubmed ID | |
| Authors |
Philip G Conaghan, Patrick Durez, Rieke E Alten, Gerd-Rüdiger Burmester, Paul P Tak, Lars Klareskog, Anca Irinel Catrina, Julie DiCarlo, Corine Gaillez, Manuela Le Bars, Xianhuang Zhou, Charles Peterfy |
| Abstract |
This randomised, double-blind, placebo-controlled phase IIIb study evaluated the impact of abatacept on MRI pathology as a primary outcome in methotrexate (MTX)-refractory patients with rheumatoid arthritis. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | 1% |
| Unknown | 89 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 18% |
| Other | 11 | 12% |
| Student > Ph. D. Student | 11 | 12% |
| Student > Bachelor | 7 | 8% |
| Student > Master | 7 | 8% |
| Other | 22 | 24% |
| Unknown | 16 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 54% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 8% |
| Agricultural and Biological Sciences | 2 | 2% |
| Engineering | 2 | 2% |
| Social Sciences | 2 | 2% |
| Other | 8 | 9% |
| Unknown | 20 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2018.
All research outputs
#4,202,008
of 22,925,760 outputs
Outputs from Annals of the Rheumatic Diseases
#2,258
of 7,248 outputs
Outputs of similar age
#29,806
of 169,550 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#19
of 80 outputs
Altmetric has tracked 22,925,760 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,248 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.1. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,550 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.